Mohammad S. Rostami

Array ( [id] => 6756357 [patent_doc_number] => 20030004134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Composition and method for potentiating drugs' [patent_app_type] => new [patent_app_number] => 09/775794 [patent_app_country] => US [patent_app_date] => 2001-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12717 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20030004134.pdf [firstpage_image] =>[orig_patent_app_number] => 09775794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1286430 [patent_doc_number] => 06638973 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-10-28 [patent_title] => 'Taxane formulations' [patent_app_type] => B2 [patent_app_number] => 09/776426 [patent_app_country] => US [patent_app_date] => 2001-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 79556 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/638/06638973.pdf [firstpage_image] =>[orig_patent_app_number] => 09776426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6973739 [patent_doc_number] => 20010003751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-06-14 [patent_title] => 'Pharmaceutical composition for treating transient ischemic attack' [patent_app_type] => new-utility [patent_app_number] => 09/769440 [patent_app_country] => US [patent_app_date] => 2001-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3524 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20010003751.pdf [firstpage_image] =>[orig_patent_app_number] => 09769440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6878251 [patent_doc_number] => 20010002406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-05-31 [patent_title] => 'Transdermal therapeutic device and method with capsaicin and capsaicin analogs' [patent_app_type] => new-utility [patent_app_number] => 09/769596 [patent_app_country] => US [patent_app_date] => 2001-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2266 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20010002406.pdf [firstpage_image] =>[orig_patent_app_number] => 09769596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416421 [patent_doc_number] => 06525182 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Guanidinylation, guanidinoglycosides, uses, and methods of assaying their activity' [patent_app_type] => B1 [patent_app_number] => 09/768026 [patent_app_country] => US [patent_app_date] => 2001-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8504 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/525/06525182.pdf [firstpage_image] =>[orig_patent_app_number] => 09768026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730787 [patent_doc_number] => 20030186977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Use of pdgf receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy' [patent_app_type] => new [patent_app_number] => 10/220214 [patent_app_country] => US [patent_app_date] => 2003-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5174 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186977.pdf [firstpage_image] =>[orig_patent_app_number] => 10220214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342503 [patent_doc_number] => 06586407 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-01 [patent_title] => 'Injectable pharmaceutical formulations for partricin derivatives' [patent_app_type] => B1 [patent_app_number] => 09/720236 [patent_app_country] => US [patent_app_date] => 2000-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3661 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586407.pdf [firstpage_image] =>[orig_patent_app_number] => 09720236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5923968 [patent_doc_number] => 20020115835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Methods utilizing aryl thioimines in synthesis of erythromycin derivatives' [patent_app_type] => new [patent_app_number] => 09/747724 [patent_app_country] => US [patent_app_date] => 2000-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6397 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115835.pdf [firstpage_image] =>[orig_patent_app_number] => 09747724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1381427 [patent_doc_number] => 06555573 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-04-29 [patent_title] => 'Method and composition for the topical treatment of diabetic neuropathy' [patent_app_type] => B2 [patent_app_number] => 09/740811 [patent_app_country] => US [patent_app_date] => 2000-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4253 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/555/06555573.pdf [firstpage_image] =>[orig_patent_app_number] => 09740811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1441196 [patent_doc_number] => 06335328 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-01-01 [patent_title] => 'Process for the isolation of galanthamine' [patent_app_type] => B2 [patent_app_number] => 09/741436 [patent_app_country] => US [patent_app_date] => 2000-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1910 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/335/06335328.pdf [firstpage_image] =>[orig_patent_app_number] => 09741436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5860129 [patent_doc_number] => 20020123625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-05 [patent_title] => 'Liquid thickener for surfactant systems' [patent_app_type] => new [patent_app_number] => 09/741514 [patent_app_country] => US [patent_app_date] => 2000-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4793 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20020123625.pdf [firstpage_image] =>[orig_patent_app_number] => 09741514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6878238 [patent_doc_number] => 20010002393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-05-31 [patent_title] => 'Methods and kits for treating and diagnosing leiomyomas' [patent_app_type] => new-utility [patent_app_number] => 09/741652 [patent_app_country] => US [patent_app_date] => 2000-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11502 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20010002393.pdf [firstpage_image] =>[orig_patent_app_number] => 09741652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1420425 [patent_doc_number] => 06514992 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Caspases and apoptosis' [patent_app_type] => B1 [patent_app_number] => 09/719724 [patent_app_country] => US [patent_app_date] => 2000-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7624 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514992.pdf [firstpage_image] =>[orig_patent_app_number] => 09719724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1407052 [patent_doc_number] => 06534647 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-18 [patent_title] => 'Surface-active alkylurethanes of fructans' [patent_app_type] => B1 [patent_app_number] => 09/719321 [patent_app_country] => US [patent_app_date] => 2000-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7060 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/534/06534647.pdf [firstpage_image] =>[orig_patent_app_number] => 09719321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6948068 [patent_doc_number] => 20010021704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-13 [patent_title] => 'Pharmaceutical compositions for the treatment of tumor diseases' [patent_app_type] => new [patent_app_number] => 09/731787 [patent_app_country] => US [patent_app_date] => 2000-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7430 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20010021704.pdf [firstpage_image] =>[orig_patent_app_number] => 09731787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4277089 [patent_doc_number] => 06281196 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Isolation and structural elucidation of the human cancer cell growth inhibitory compound denominated agelagalastatin' [patent_app_type] => 1 [patent_app_number] => 9/719082 [patent_app_country] => US [patent_app_date] => 2000-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5852 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/281/06281196.pdf [firstpage_image] =>[orig_patent_app_number] => 719082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1462937 [patent_doc_number] => 06350773 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-26 [patent_title] => 'Therapeutic combinations of (S)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro 7H-1,4-dioxino2,3-eindol-8-one and neuroleptics for the treatment or prevention of psychotic disorders' [patent_app_type] => B1 [patent_app_number] => 09/728994 [patent_app_country] => US [patent_app_date] => 2000-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3574 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/350/06350773.pdf [firstpage_image] =>[orig_patent_app_number] => 09728994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5987945 [patent_doc_number] => 20020099185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Malto-oligosaccharide derived glycosides' [patent_app_type] => new [patent_app_number] => 09/726708 [patent_app_country] => US [patent_app_date] => 2000-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5099 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20020099185.pdf [firstpage_image] =>[orig_patent_app_number] => 09726708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5952293 [patent_doc_number] => 20020007071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-17 [patent_title] => 'Benzimidzolyl neuropeptide Y receptor antagonists' [patent_app_type] => new [patent_app_number] => 09/726276 [patent_app_country] => US [patent_app_date] => 2000-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50552 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0007/20020007071.pdf [firstpage_image] =>[orig_patent_app_number] => 09726276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1031181 [patent_doc_number] => 06878733 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-04-12 [patent_title] => 'Formulations for pharmaceutical agents ionizable as free acids or free bases' [patent_app_type] => utility [patent_app_number] => 09/716332 [patent_app_country] => US [patent_app_date] => 2000-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 82254 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/878/06878733.pdf [firstpage_image] =>[orig_patent_app_number] => 09716332 [rel_patent_id] =>[rel_patent_doc_number] =>)